Pyxis Oncology Ownership | Who Owns Pyxis Oncology?


OverviewForecastRevenueFinancialsChart

Pyxis Oncology Ownership Summary


Pyxis Oncology is owned by 45.93% institutional investors, 24.54% insiders, and 29.53% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 8.16% of PYXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.18% of its assets in Pyxis Oncology shares.

PYXS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPyxis Oncology45.93%24.54%29.53%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deep track capital, lp4.18M8.16%$13.85M
Laurion capital management lp3.86M7.53%$12.78M
Blackrock2.79M5.43%$9.22M
Balyasny asset management2.56M5.00%$8.48M
Vanguard group2.06M4.02%$6.82M
Stempoint capital lp1.20M2.34%$3.98M
Blue owl capital lp1.05M2.04%$3.46M
Geode capital management1.03M2.00%$3.40M
State street742.91K1.45%$2.46M
Abrdn708.30K1.38%$2.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stempoint capital lp1.20M1.17%$3.98M
Blue owl capital lp1.05M0.96%$3.46M
Deep track capital, lp4.18M0.41%$13.85M
Decheng capital326.81K0.33%$1.08M
Yu fan69.30K0.30%$229.39K
Cable car capital61.61K0.21%$203.92K
Ikarian capital3.59K0.21%$1.19M
Laurion capital management lp3.86M0.15%$12.78M
University of chicago48.73K0.12%$161.30K
Pier 88 investment partners113.70K0.08%$376.35K

Top Buyers

HolderShares% AssetsChange
Blackrock2.79M0.00%2.46M
Blue owl capital lp1.05M0.96%1.05M
Geode capital management1.03M0.00%687.59K
Vanguard group2.06M0.00%659.02K
State street742.91K0.00%633.55K

Top Sellers

HolderShares% AssetsChange
Stempoint capital lp1.20M1.17%-591.52K
Superstring capital management lp---484.44K
Monashee investment management---442.50K
Goldman sachs group117.25K0.00%-219.44K
Jane street group35.21K--140.04K

New Positions

HolderShares% AssetsChangeValue
Blue owl capital lp1.05M0.96%1.05M$3.46M
Nuveen asset management149.02K0.00%149.02K$493.27K
Boothbay fund management99.10K0.01%99.10K$328.02K
Rhumbline advisers65.29K0.00%65.29K$216.09K
Simplex trading40.76K0.00%40.76K$134.00K

Sold Out

HolderChange
Fmr-1.00
West branch capital-25.00
Allworth financial lp-200.00
Macquarie group-1.11K
Redwood wealth management group-1.40K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20249919.28%27,885,908-0.82%451.53%5422.73%15-37.50%
Jun 30, 2024839.21%28,117,59922.50%542.08%44-18.52%24500.00%
Mar 31, 20247646.15%22,952,291161.33%5111.36%54200.00%4-63.64%
Dec 31, 2023524.00%8,782,94513.39%215.22%18-30.77%11-15.38%
Sep 30, 2023506.38%7,745,767-19.36%202.73%26-23.53%13116.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.29M2.18%-
iShares Russell 2000 ETF1.23M2.07%-2.77K
Vanguard Institutional Extnd Mkt Idx Tr782.88K1.32%-
HBM Healthcare Investments AG Ord717.82K1.21%-
abrdn Healthcare Investors626.64K1.05%-
Fidelity Small Cap Index500.44K0.84%-12.49K
iShares Russell 2000 Value ETF492.03K0.83%-
State St Russell Sm/Mid Cp® Indx NL Cl C287.79K0.48%-10.00K
abrdn Life Sciences Investors286.41K0.48%-
Fidelity Extended Market Index264.30K0.44%-9.84K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 26, 2024Connealy Pamela Ann CFO & COOBuy$10.90K
Nov 26, 2024Connealy Pamela Ann CFO & COOBuy$163.46K
Sep 28, 2023Connealy Pamela Ann CFO and COOBuy$14.96K
Sep 27, 2023Wadhane Jitendra Chief Accounting OfficerBuy$4.67K
Sep 27, 2023Connealy Pamela Ann CFO and COOBuy$11.87K

Insider Transactions Trends


DateBuySell
2024 Q42-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q375

PYXS Ownership FAQ


Who Owns Pyxis Oncology?

Pyxis Oncology shareholders are primarily institutional investors at 45.93%, followed by 24.54% insiders and 29.53% retail investors. The average institutional ownership in Pyxis Oncology's industry, Biotech Stocks , is 47.04%, which Pyxis Oncology falls below.

Who owns the most shares of Pyxis Oncology?

Pyxis Oncology’s largest shareholders are Deep track capital, lp (4.18M shares, 8.16%), Laurion capital management lp (3.86M shares, 7.53%), and Blackrock (2.79M shares, 5.43%). Together, they hold 21.12% of Pyxis Oncology’s total shares outstanding.

Does Blackrock own Pyxis Oncology?

Yes, BlackRock owns 5.43% of Pyxis Oncology, totaling 2.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.22M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 766.09% change.

Who is Pyxis Oncology’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is Pyxis Oncology’s biggest shareholder by percentage of total assets invested, with 1.17% of its assets in 1.2M Pyxis Oncology shares, valued at 3.98M$.

Who is the top mutual fund holder of Pyxis Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Pyxis Oncology shares, with 2.18% of its total shares outstanding invested in 1.29M Pyxis Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools